BioCardia BCDA
NASDAQ BCDA
$1.10 -0.01 (-0.90%)
At close: Sep 9, 2026 · 4:00 PM EDT

BioCardia (BCDA) Other Non Operating Income (2016 - 2021)

BioCardia's (BCDA) quarterly Other Non Operating Income came in at -$1000.0 in Q4 2021, down 100.2% year-over-year from $512000.0 in Q4 2020, and little changed quarter-over-quarter from -$1000.0 in Q1 2021.

Analysis

BioCardia (BCDA) Other Non Operating Income (2016 - 2021) Analysis & Trends

BioCardia (BCDA) has reported Other Non Operating Income for 6 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2021.

  • On a quarterly basis, Other Non Operating Income fell 100.2% year-over-year to -$1000.0 in Q4 2021; TTM through Dec 2021 was -$2000.0, a 100.39% decrease from a year earlier, with the FY2021 full-year figure at -$2000.0, down 100.39% from the prior year.
  • Other Non Operating Income was -$1000.0 for Q4 2021 at BioCardia, roughly flat from -$1000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $573000.0 in Q4 2019 and troughed at -$521000.0 in Q3 2019.
  • A 5-year average of $42769.2 and a median of -$1000.0 in 2017 frame the typical range for Other Non Operating Income.
  • Across the five-year window, Other Non Operating Income plunged 17266.67% in 2019 and jumped 99.81% in 2020, its largest moves.
  • Over 5 years, Other Non Operating Income stood at $3000.0 in 2017, then slumped by 200.0% to -$3000.0 in 2018, then jumped by 19200.0% to $573000.0 in 2019, then slipped by 10.65% to $512000.0 in 2020, then sank by 100.2% to -$1000.0 in 2021.
  • The last three Other Non Operating Income figures came in at -$1000.0 (Q4 2021), -$1000.0 (Q1 2021), and $512000.0 (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn
10 BioCardia 13.06 Mn 8.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -1,000.00
Mar 31, 2021 -1,000.00
Dec 31, 2020 512,000.00
Sep 30, 2020 -1,000.00
Jun 30, 2020 -1,000.00
Mar 31, 2020 -1,000.00
Dec 31, 2019 573,000.00
Sep 30, 2019 -521,000.00
Jun 30, 2019 -1,000.00
Mar 31, 2019 -1,000.00
Sep 30, 2018 -3,000.00
Sep 30, 2017 3,000.00
Mar 31, 2017 -1,000.00
Dec 31, 2016 -1,000.00
Jun 30, 2016 -1,000.00